Codes ATC:
J01FA10
EMLc
Indication
Infectious gastroenteritis or colitis without specification of infectious agent
Code ICD11:
1A70.Z
INN
Azithromycin
Type de médicament
Chemical agent
Groupes d'antibiotiques
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Additional notes
*also listed for single-dose treatment of trachoma and yaws
Formulations
Oral > Liquid:
200 mg per 5 mL (anhydrous) powder for oral liquid
(EMLc)
Oral > Solid > dosage form: 250 mg (anhydrous) ; 500 mg (anhydrous)
Oral > Solid > dosage form: 250 mg (anhydrous) ; 500 mg (anhydrous)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc.
- replacing the oral liquid formulation of azithromycin (200 mg/5 mL) with powder for oral liquid 200 mg/5 mL on the EML and EMLc.
- the addition of a new strength formulation of ciprofloxacin (solid oral dosage form 100 mg (as hydrochloride)) to the EMLc.
- the addition of a new strength formulation of sulfamethoxazole + trimethoprim (dispersible tablet 100 mg + 20 mg) on the EMLc.
Recommandations de la LME : Infectious gastroenteritis or colitis without specification of infectious agent
Premier choix
Second choix
Premier choix
Second choix